Frankfurt
27.10.26 | 08:02
6,280 Euro
0,00 % 0,000
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 28.10. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 28.10.2026 | 1.270 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 28.10.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 28.10.2026ISIN NameAU000000EUR7 EUROPEAN... ► Artikel lesen | |
| 28.10. | XFRA 47H: AUSSETZUNG/SUSPENSION | 165 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILHUMANA AB 47H SE0008040653... ► Artikel lesen | |
| 22.10. | Humana AB Announces Climb In Q3 Profit | 3 | RTTNews | ||
| 22.10. | Humana AB: Humana reports third quarter and nine-month period 2026 results | 242 | GlobeNewswire (Europe) | Highest profit in a quarter and improved margin
President and CEO Nathalie Boulas Nilsson comments:The third quarter of 2026 continued in a positive direction, with our highest adjusted operating profit... ► Artikel lesen | |
| 15.10. | Ambea AB: Ambea AB (publ) announces final outcome of the recommended public offer to the shareholders of Humana AB | 359 | GlobeNewswire (Europe) | This press release does not constitute an offer, either directly or indirectly, in Australia, Hong Kong, Japan, New Zealand or South Africa, or in any other jurisdiction where an offer would be prohibited... ► Artikel lesen | |
| HUMANA AB Aktie jetzt für 0€ handeln | |||||
| 13.10. | Humana AB - Removal from trading on Nasdaq Stockholm | 282 | GlobeNewswire | Humana AB has applied for its shares to be removed from trading on Nasdaq Stockholm.
Nasdaq Stockholm AB has approved the application and decided to remove the shares of Humana AB from trading... ► Artikel lesen | |
| 13.10. | Humana AB: Delisting of Humana | 239 | GlobeNewswire (Europe) | Nasdaq Stockholm has decided that Humana AB will be delisted from Nasdaq Stockholm. The last day of trading in the share will be on 27 October 2026.For more information, please contact: Ewelina PetterssonHead... ► Artikel lesen | |
| 06.10. | Humana AB: Humana applies for delisting and convenes an Extraordinary General Meeting | 325 | GlobeNewswire (Europe) | Ambea AB (publ) ("Ambea") declared the public takeover offer for Humana AB ("Humana" or the "Company") unconditional on 1 October 2026. Ambea controls more than 90 per cent of the shares in Humana and... ► Artikel lesen | |
| 02.10. | Humana AB: Humana appoints Jenny Karlsson as Business Area Manager of Humana Assistans | 326 | GlobeNewswire (Europe) | Humana AB has appointed Jenny Karlsson as acting Business Area Manager for Humana Assistans. Jenny Karlsson comes from the role of Deputy Business Area Manager and will assume her new role on November... ► Artikel lesen | |
| 01.10. | Ambea AB: Ambea Completes The Recommended Public Offer To The Shareholders Of Humana AB And Extends The Acceptance Period | 620 | GlobeNewswire (Europe) | This press release does not constitute an offer, either directly or indirectly, in Australia, Hong Kong, Japan, New Zealand or South Africa, or in any other jurisdiction where an offer would be prohibited... ► Artikel lesen | |
| 08.09. | AMBEA AB (PUBL) HAS COMPLETED THE SHARE REPURCHASE PROGRAM IN CONNECTION WITH THE RECOMMENDEDIC OFFER TO THE SHAREHOLDERS OF HUMANA AB | 2 | Cision News | ||
| 14.08. | Humana AB: The Court of Appeal grants leave to appeal for Humana Assistans AB's appeal of the District Court's decision to reject the damage claim against the state | 339 | GlobeNewswire (Europe) | On 25 June 2026, Humana Assistans decided to appeal the District Court's decision to reject Humana Assistans's damage claim against the state. The Court of Appeal has today, August 14, 2026, decided... ► Artikel lesen | |
| 17.07. | Humana AB: Humana reports second quarter and half-year 2026 results | 566 | GlobeNewswire (Europe) | Continued improvement in profitability
Summary of the second quarter· Net revenue was SEK 2,581 million (2,506), representing an increase of 3 percent.· Organic growth was -0.3 percent (-1.5).· Operating... ► Artikel lesen | |
| 29.06. | Humana AB receives observation status | 636 | GlobeNewswire | Today, June 29, 2026, Ambea AB (publ) disclosed a public takeover offer to the shareholders of Humana AB (the "Company").
According to item 4.1.1 (d) of the Nasdaq Nordic Main Market Rulebook... ► Artikel lesen | |
| 29.06. | Humana AB Aktie: Kurssprung nach Übernahmeangebot von Ambea | 7 | Investing.com Deutsch | ||
| 29.06. | Invitation: Presentation regarding Ambea's public offer to the shareholders of Humana AB | 3 | Cision News | ||
| 29.06. | Ambea AB: Ambea Resolves On Repurchase Of Own Shares In Connection With The Recommended Public Offer To The Shareholders Of Humana Ab | 583 | GlobeNewswire (Europe) | The Board of Directors of Ambea AB (publ) ("Ambea") has resolved to repurchase a maximum of 5,560,658 own shares on Nasdaq Stockholm. The resolution is made by virtue of the authorisation to repurchase... ► Artikel lesen | |
| 29.06. | Humana AB: Statement by the Board of Directors of Humana regarding Ambea's public takeover offer | 1.838 | GlobeNewswire (Europe) | The Board of Directors of Humana unanimously recommends the shareholders of Humana to accept the public takeover offer from Ambea.
BackgroundThis statement is made by the Board of Directors (the "Board")... ► Artikel lesen | |
| 29.06. | Ambea AB: Ambea Announces A Recommended Public Offer To The Shareholders Of Humana AB To Tender All Their Shares In Humana Ab, Aiming To Combine The Companies | 765 | GlobeNewswire (Europe) | This press release does not constitute an offer, either directly or indirectly, in Australia, Hong Kong, Japan, New Zealand or South Africa, or in any other jurisdiction where an offer would be prohibited... ► Artikel lesen | |
| 26.06. | Humana AB: Humana Finland expands its pipeline for organic growth | 278 | GlobeNewswire (Europe) | Over the past year, Humana has strengthened its focus on organic growth, including a strengthened sales organization in Finland. The expansion is primarily driven by demand within disability, and a... ► Artikel lesen |
1 2 Weiter >>
32 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 53,36 | +1,72 % | Ihre wichtigsten Termine: Frische Zahlen von: Uber, Novo Nordisk, Qualcomm, Allstate, McDonald's und BMW | © Foto: Steffen Trumpf/dpaGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag Enthaltene Werte: US0200021014... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 41,060 | +0,22 % | JEFFERIES stuft FMC FRESENIUS MEDICAL CARE AG auf 'Underperform' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Fresenius Medical Care (FMC) nach Zahlen zum dritten Quartal auf "Underperform" mit einem Kursziel von 30 Euro belassen.... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 43,260 | +0,23 % | Ihre wichtigsten Termine: Heute im Fokus: Rheinmetall, Cloudflare, MP Materials, Airbnb, Lyft und Telekom | © Foto: Julian Stratenschulte/dpa Gut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag Enthaltene Werte:... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 34,320 | +1,00 % | 0,60 Dioptrien weniger Fortschreiten: Warum ZEISS bei Kinderbrillen auf dynamische Signale setzt | ||
| ECKERT & ZIEGLER | 13,830 | 0,00 % | Eckert&Ziegler im Check: Quartalszahlen rücken näher - hält der Rückenwind? | ||
| INTUITIVE SURGICAL | 410,70 | +0,01 % | ISRG Gains 7.8% in 6 Months: Will the Share Price Recovery Continue? | ||
| UNITEDHEALTH | 356,60 | +0,56 % | UnitedHealth Group adds former CHOP CEO to board | ||
| DRAEGERWERK | 100,60 | -1,18 % | Drägerwerk führt, Sartorius hängt Carl Zeiss Meditec ab: Drei Aktien, drei sehr verschiedene Signale | ||
| MEDTRONIC | 91,94 | +0,35 % | Medtronic: What Wild Hearts Reveal | Medtronic LINQ insertable cardiac monitors track animal heart activity worldwide, revealing insights into stress, survival, and what "normal" means across species. NORTHAMPTON, MA / ACCESS Newswire... ► Artikel lesen | |
| GERRESHEIMER | 31,000 | 0,00 % | EQS-PVR: Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Gerresheimer AG
Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of... ► Artikel lesen | |
| THERMO FISHER | 647,00 | +0,62 % | Thermo Fisher Scientific: 5-Milliarden-Rückkauf, aber die Aktie fällt - der Haken | ||
| TELADOC HEALTH | 8,004 | +0,08 % | Teladoc Health, Inc.: Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08 | ||
| STRATEC | 24,800 | +0,40 % | BERENBERG stuft STRATEC BIOMEDICAL SYSTEMS AG auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Stratec von 37 auf 39 Euro angehoben und die Einstufung auf "Buy" belassen. Das neue Kursziel resultiere aus dem angekündigten... ► Artikel lesen | |
| RHOEN-KLINIKUM | 14,800 | +2,78 % | Klinik für Anästhesiologie und Intensivmedizin am RHÖN-KLINIKUM Campus Bad Neustadt unter neuer Leitung | Bad Neustadt a.d. Saale (ots) - Dr. Stefan Reisch übernimmt Chefarztposition - langjähriger Mitarbeiter am Standort Bad NeustadtDie Klinik für Anästhesiologie und Intensivmedizin am RHÖN-KLINIKUM Campus... ► Artikel lesen | |
| ESSILORLUXOTTICA | 188,80 | -1,51 % | Erben blockieren Mega-Deal: Machtkampf um 43 Milliarden Euro: Droht EssilorLuxottica ein Beben? | © Foto: SOPA Images - Sipa USAEin Erbstreit um 43 Milliarden Euro erschüttert das Ray-Ban-Imperium. Vier Erben blockieren einen Milliardendeal. Bei EssilorLuxottica wächst die Unsicherheit Enthaltene... ► Artikel lesen |
Das Unternehmen HUMANA AB kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 6,280 Euro und damit 0,00 % im Plus. Beim derzeitigen Kurs ergibt sich, basierend auf einer gesamten Ausschüttung von 0,00 Euro in den vergangenen 12 Monaten, eine Dividendendrendite von 0,00 %.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu HUMANA AB finden Sie auf Wallstreet Online.